AAF
WST icon

Andra AP-fonden’s West Pharmaceutical WST Stock Holding History

Andra AP-fonden’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8M Buy
55,007
+48,327
+723% +$12M 0.16% 154
2025
Q4 		$1.84M Buy
+6,680
New +$1.83M 0.02% 366
2024
Q4 		– Sell
-26,000
Closed -$7.8M – 465
2024
Q3 		$7.8M Buy
26,000
+1,000
+4% +$306K 0.11% 258
2024
Q2 		$8.23M Buy
25,000
+4,700
+23% +$1.66M 0.14% 233
2024
Q1 		$8.03M Buy
+20,300
New +$7.51M 0.14% 220
2023
Q3 		– Sell
-25,200
Closed -$9.64M – 574
2023
Q2 		$9.64M Sell
25,200
-500
-2% -$179K 0.24% 120
2023
Q1 		$8.9M Sell
25,700
-18,200
-41% -$5.32M 0.23% 155
2022
Q4 		$10.3M Buy
43,900
+3,500
+9% +$829K 0.31% 49
2022
Q3 		$9.94M Buy
40,400
+5,900
+17% +$1.8M 0.33% 53
2022
Q2 		$10.4M Buy
+34,500
New +$11.2M 0.3% 69
2021
Q4 		$16M Sell
34,200
-300
-0.9% -$129K 0.33% 48
2021
Q3 		$14.6M Buy
34,500
+3,000
+10% +$1.26M 0.3% 53
2021
Q2 		$11.3M Sell
31,500
-1,000
-3% -$330K 0.23% 130
2021
Q1 		$9.16M Sell
32,500
-16,200
-33% -$4.64M 0.2% 209
2020
Q4 		$13.8M Sell
48,700
-3,500
-7% -$982K 0.3% 32
2020
Q3 		$14.3M Buy
52,200
+7,800
+18% +$2.06M 0.39% 6
2020
Q2 		$10.1M Buy
44,400
+11,600
+35% +$2.28M 0.29% 15
2020
Q1 		$4.99M Sell
32,800
-5,800
-15% -$893K 0.18% 185
2019
Q4 		$5.8M Buy
+38,600
New +$5.62M 0.17% 286

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Andra AP-fonden's WST Position: Q1 2026 in Review

Andra AP-fonden increased its West Pharmaceutical (WST) stake by 723% in Q1 2026, buying an estimated $12M and bringing the position to 55,007 shares worth $13.8M. The position accounts for 0.16% of the portfolio, ranked #154.

Andra AP-fonden first reported a position in WST in Q4 2019 and has held it in 19 quarters since. The position peaked at $16M in Q4 2021. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Andra AP-fonden held 55,007 shares of West Pharmaceutical worth $13.8M as of Q1 2026.
  • Andra AP-fonden bought 48,327 West Pharmaceutical shares in Q1 2026, an estimated $12M.
  • West Pharmaceutical made up 0.16% of Andra AP-fonden's portfolio in Q1 2026, its #154 holding.
  • Andra AP-fonden first reported a position in West Pharmaceutical in Q4 2019 and has held it in 19 quarters since.
  • Andra AP-fonden's West Pharmaceutical position peaked at $16M in Q4 2021.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.